Home › Research › Brain scans and imaging
Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study
Korf ES, White LR, Scheltens P, Launer LJ.. Hypertension (Dallas, Tex. : 1979), 2004-05-24
Topic: Risk, prevention and care in population studies
Plain-language summary
Hippocampal atrophy (HA) is usually attributed to the neurofibrillary tangles and neuritic plaques of Alzheimer disease. However, the hippocampus is vulnerable to global ischemia, which may lead to atrophy. We investigated the association of midlife blood pressure (BP) and late-life HA in a sample of Japanese-American men born between 1900 and 1919. BP was measured on 3 occasions between 1965 and 1971. In 1994 to 1996 a subsample underwent magnetic resonance imaging (MRI) of the brain. Hippocampal volume was estimated by manually drawing regions of interest on relevant scan slices; HA was defined as the lowest quartile of hippocampal volume. Also assessed on the MRI were cortical and subcortical infarcts, lacunes, and white matter hyperintensities. The risk (OR, 95% CI) was estimated for HA associated with systolic ( or =140 mm Hg) and diastolic ( or =90 mm Hg) BP and with antihypertensive treatment. Analyses were adjusted for sociodemographic factors, other cardiovascular risk factors, apolipoprotein E allele, and correlated brain pathology. Those never treated with antihypertensive medication had a significantly increased risk for HA (OR 1.7; CI=1.12; 2.65). The nontreated subjects with high systolic BP had an increased risk (OR=1.98; CI=0.89; 4.39) for HA. Results were similar for untreated men with high diastolic BP (OR=3.51; CI=1.26; 9.74). In conclusion, treatment with antihypertensive treatment modifies the association of BP and HA, such that high levels of BP adversely affect the hippocampus in persons never treated with antihypertensives.
What this study adds
Evidence grade: Low
In Japanese-American men, those never treated with antihypertensive medication had a significantly increased risk of hippocampal atrophy, with higher risks in untreated men with high systolic or diastolic blood pressure. Reported effect size: OR 1.7; OR=1.98; OR=3.51.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Korf, E. S., White, L. R., Scheltens, P., & Launer, L. J. (2004). Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension (Dallas, Tex. : 1979). https://doi.org/10.1161/01.hyp.0000132475.32317.bb
Vancouver
Korf ES, White LR, Scheltens P, Launer LJ. Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study. Hypertension (Dallas, Tex. : 1979). 2004. doi:10.1161/01.hyp.0000132475.32317.bb. PMID: 15159381.
BibTeX
@article{korf2004-15159381,
author = {Korf, E. S. and White, L. R. and Scheltens, P. and Launer, L. J.},
title = {{Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study}},
journal = {Hypertension (Dallas, Tex. : 1979)},
year = {2004},
doi = {10.1161/01.hyp.0000132475.32317.bb},
pmid = {15159381},
url = {https://doi.org/10.1161/01.hyp.0000132475.32317.bb}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The risk (OR, 95% CI) was estimated for HA associated with systolic ( or =140 mm Hg) and diastolic ( or =90 mm Hg) BP and with antihypertensive treatment.
- Those never treated with antihypertensive medication had a significantly increased risk for HA (OR 1.7; CI=1.12; 2.65).
- The nontreated subjects with high systolic BP had an increased risk (OR=1.98; CI=0.89; 4.39) for HA.
- Results were similar for untreated men with high diastolic BP (OR=3.51; CI=1.26; 9.74).
- In conclusion, treatment with antihypertensive treatment modifies the association of BP and HA, such that high levels of BP adversely affect the hippocampus in persons never treated with antihypertensives.
Why it matters
In Japanese-American men, those never treated with antihypertensive medication had a significantly increased risk of hippocampal atrophy, with higher risks in untreated men with high systolic or diastolic blood pressure. This links midlife blood pressure to later hippocampal atrophy, but it does not show that blood pressure treatment prevents Alzheimer disease.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Effect sizeOR 1.7; OR=1.98; OR=3.51
- Evidence strengthLow
How this study scored 51/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Hypertension (Dallas, Tex. : 1979)) |
| Journal's citation record | 3 / 4 | Hypertension: journal h-index 369 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2004 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 254 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 10.6 citations a year over 24 year(s) since 2004 |
| Impact for its field and year | 3 / 6 | Cited 7.2× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 14 other studies in this library |
| Still being cited | 1 / 4 | Cited 9 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Lenore J. Launer: h-index 180 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | National Institutes of Health: institution h-index 2,723 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 15159381) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1161/01.hyp.0000132475.32317.bb
- PubMed: 15159381
- Original source →
- Free full text: Hypertension →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
14 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Brain scans and imaging from nearby years
Also tagged “disorder”
492 studies in the library carry the topic tag “disorder”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 492 tagged studies.